Neuphoria Therapeutics Inc (NEUP) Balance Sheet
NEUP balance sheet, FY2026
June 30, 2026 · U.S. dollars$28.71B assets = $4.11B liabilities + $24.60B equity
Both columns are drawn to the same scale: what NEUP owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NEUP financial health
Descriptive bands, not a rating. Fiscal FY2026.
NEUP balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $64.6MFY2017 | $28.71BFY2026 | +96.9%/yr | |
| Total liabilities | $33.5MFY2017 | $4.11BFY2026 | +70.6%/yr | |
| Shareholders’ equity | $31.1MFY2017 | $24.60BFY2026 | +109.9%/yr | |
| Cash & short-term investments | $33.4MFY2017 | $19.87BFY2026 | +103.4%/yr | |
| Total debt | $14.2MFY2017 | $34,345FY2026 | −48.8%/yr | |
| Net cash (debt) | $19.1MFY2017 | $19.87BFY2026 | +$19.8B | |
| Working capital | $31.2MFY2017 | $20.31BFY2026 | +$20.3B | |
| Book value per share | $17.79FY2025 | $5,596.00FY2026 | +31,355.1%/yr | |
| Debt / equity | 0.46FY2017 | 0.00FY2026 | −0.46 | |
| Shares outstanding | 1.6MFY2025 | 4.4MFY2026 | +170.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NEUP assets
NEUP liabilities and equity
NEUP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NEUP balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $19.87B | $21.6M | $12.6M | $8.1M | $33.6M | $21.4M | $3.1M | $10.2M | $18.7M | $33.4M |
| Cash & equivalents | $19.87B | $21.6M | $12.6M | $8.1M | $33.6M | $21.4M | $3.1M | $9.8M | $18.3M | $32.9M |
| Short-term investments | — | — | — | — | — | $327,312 | — | $385,186 | $404,025 | $422,647 |
| Receivables | $813,431 | $11,948 | $126,884 | $283,624 | $6.8M | $192,885 | $40,739 | $621,017 | $523,501 | $7.6M |
| Inventory | $0 | $0 | $0 | $0 | $1 | $2 | $1 | $465,403 | $360,016 | $327,161 |
| Other current assets | $1.20B | $1.2M | $459,116 | $530,842 | $1.5M | $1.6M | $2.5M | $6.3M | $6.8M | $565,807 |
| Total current assets | $21.07B | $22.9M | $13.2M | $8.9M | $41.8M | $23.2M | $5.7M | $17.6M | $26.4M | $41.9M |
| Property, plant & equipment (net) | $0 | $160,118 | $218,969 | $221,661 | $674,458 | $654,372 | $724,901 | $1.8M | $2.0M | $2.0M |
| Goodwill & intangible assets | $7.64B | $20.4M | $14.2M | $9.9M | $22.7M | $16.8M | $16.9M | $18.0M | $19.1M | $20.4M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $119,000 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $2 | $78,031 | $433,363 | $118,991 | $0 | $299,705 | $268,932 | $282,085 | $295,087 |
| Total assets | $28.71B | $43.4M | $27.6M | $19.4M | $65.3M | $40.8M | $23.7M | $37.6M | $47.8M | $64.6M |
| Liabilities | ||||||||||
| Accounts payable | $385,584 | $1.8M | $2.2M | $958,064 | $1.6M | $772,933 | $866,778 | $842,301 | $2.6M | $1.5M |
| Short-term debt | $34,345 | $226,487 | $155,110 | $269,379 | $160,023 | $130,896 | $4.1M | $5.9M | $4.3M | $6.5M |
| Deferred revenue | — | — | — | — | — | — | — | $158,091 | $64,167 | $14,991 |
| Total current liabilities | $756.6M | $6.4M | $3.8M | $4.1M | $3.4M | $1.8M | $5.7M | $9.7M | $9.8M | $10.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | — | $239,618 | $353,765 | $477,150 | $652,041 | — | — | — | — |
| Other long-term liabilities | $3.35B | $8.2M | $6.3M | $2.9M | $5.0M | $3.2M | $9.3M | $15.5M | $25.6M | $22.8M |
| Total liabilities | $4.11B | $14.6M | $10.2M | $4.7M | $8.4M | $5.0M | $15.0M | $25.2M | $35.3M | $33.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $54,000 | $29 | $11 | — | $217.7M | $142.9M | $101.8M | $101.5M | $99.3M | $103.4M |
| Retained earnings (deficit) | −$191.80B | −$271.0M | −$178.0M | −$108.2M | −$173.3M | −$115.7M | −$102.3M | −$98.7M | −$96.5M | −$83.1M |
| Accumulated other comprehensive income | −$2.06B | −$4.3M | −$3.0M | $3.2M | $12.5M | $8.6M | $9.2M | $9.5M | $9.6M | $10.8M |
| Total shareholders' equity | $24.60B | $28.9M | $17.5M | $14.7M | $56.9M | $35.8M | $8.7M | $12.4M | $12.5M | $31.1M |
| Key figures | ||||||||||
| Total debt | $34,345 | $226,487 | $272,738 | $582,348 | $693,548 | $652,041 | $8.4M | $12.0M | $15.8M | $14.2M |
| Net cash (debt) | $19.87B | $21.4M | $12.3M | $7.5M | $32.9M | $20.8M | −$5.3M | −$1.8M | $2.9M | $19.1M |
| Working capital | $20.31B | $16.4M | $9.4M | $4.7M | $38.5M | $21.5M | $41,772 | $7.9M | $16.6M | $31.2M |
| Tangible book value | $16.96B | $8.4M | $3.3M | $4.8M | $34.2M | $19.0M | −$8.2M | −$5.6M | −$6.7M | $10.6M |
| Book value per share | $5,596.00 | $17.79 | — | — | — | — | — | — | — | — |
| Shares outstanding | 4.4M | 1.6M | — | — | — | — | — | — | — | — |
| Current ratio | 27.85 | 3.56 | 3.45 | 2.15 | 12.46 | 13.10 | 1.01 | 1.82 | 2.70 | 3.92 |
| Quick ratio | 26.26 | 3.37 | 3.33 | 2.02 | 12.02 | 12.18 | 0.56 | 1.12 | 1.97 | 3.84 |
| Debt / equity | 0.00 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 | 0.96 | 0.97 | 1.27 | 0.46 |
| Equity / assets | 85.7% | 66.5% | 63.3% | 75.5% | 87.1% | 87.7% | 36.8% | 33.0% | 26.1% | 48.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & short-term investments | $19.9M | $19.4M | $22.2M | $13.6M | $21.6M | $17.0M | $4.3M | $8.1M | $12.6M | $10.1M | $8.1M |
| Cash & equivalents | $19.9M | $19.4M | $22.2M | $13.6M | $21.6M | $17.0M | $4.3M | $8.1M | $12.6M | $14.9M | $8.1M |
| Receivables | $813,431 | $1.6M | $1.1M | $1,758 | $11.9M | $24,592 | $35,561 | $115,960 | $126,884 | $423,107 | $115,960 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $389,772 | $611,913 | $106,601 | $300,883 | $0 | $20,408 | $18,439 | $231,040 | $459,116 | $6.3M | $231,108 |
| Total current assets | $21.1M | $21.7M | $23.4M | $14.0M | $22.9M | $17.1M | $4.4M | $8.4M | $13.2M | $16.9M | $8.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $77,792 | $160,118 | $126,836 | $152,202 | $199,411 | $218,969 | $416,178 | $199,411 |
| Goodwill & intangible assets | $7.6M | $13.2M | $13.2M | $13.3M | $20.4M | $13.4M | $13.5M | $14.2M | $14.2M | $21.5M | $14.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $81,075 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $2 | $75,164 | $73,798 | $82,589 | $78,031 | $37,943 | $82,491 |
| Total assets | $28.7M | $34.8M | $36.6M | $27.3M | $43.4M | $30.7M | $18.2M | $22.9M | $27.6M | $38.9M | $22.9M |
| Liabilities | |||||||||||
| Accounts payable | $385,584 | $627,185 | $520,709 | $1.4M | $1.8M | $745,336 | $1.5M | $1.3M | $2.2M | $2.6M | $1.3M |
| Short-term debt | $34,345 | $34,225 | $33,465 | $118,220 | $226,487 | $153,138 | $149,577 | $164,541 | $155,110 | $1.3M | $164,541 |
| Total current liabilities | $756,581 | $1.5M | $2.6M | $5.1M | $6.4M | $1.6M | $2.1M | $2.6M | $3.8M | $4.4M | $2.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $0 | $0 | $85,210 | — | $141,060 | $168,310 | $219,350 | $239,618 | $305,773 | — |
| Other long-term liabilities | $3.4M | $3.9M | $4.3M | $9.7M | $8.2M | $3.2M | $2.3M | $3.3M | $6.3M | $5.4M | $3.3M |
| Total liabilities | $4.1M | $5.4M | $6.9M | $14.8M | $14.6M | $4.7M | $4.4M | $5.8M | $10.2M | $9.8M | $5.8M |
| Shareholders' equity | |||||||||||
| Common stock & paid-in capital | $54 | $54 | $54 | $23 | $29 | $19 | $16 | — | $11 | $233.9M | — |
| Retained earnings (deficit) | −$191.8M | −$186.9M | −$186.4M | −$188.3M | −$271.0M | −$169.5M | −$180.7M | −$178.8M | −$178.0M | −$218.7M | −$178.8M |
| Accumulated other comprehensive income | −$2.1M | −$2.1M | −$2.2M | −$2.8M | −$4.3M | −$3.9M | −$3.7M | −$2.4M | −$3.0M | $13.8M | −$2.4M |
| Total shareholders' equity | $24.6M | $29.4M | $29.7M | $12.5M | $28.9M | $26.0M | $13.7M | $17.1M | $17.5M | $29.0M | $17.1M |
| Key figures | |||||||||||
| Total debt | $34,345 | $34,225 | $33,465 | $118,220 | $226,487 | $172,460 | $199,395 | $254,010 | $272,738 | $1.6M | $254,010 |
| Net cash (debt) | $19.8M | $19.4M | $22.1M | $13.5M | $21.4M | $16.9M | $4.1M | $7.8M | $12.3M | $8.6M | $7.8M |
| Working capital | $20.3M | $20.1M | $20.8M | $8.8M | $16.4M | $15.5M | $2.3M | $5.9M | $9.4M | $12.4M | $5.9M |
| Tangible book value | $17.0M | $16.3M | $16.5M | −$803,655 | $8.4M | $12.6M | $205,000 | $2.9M | $3.3M | $7.6M | $2.9M |
| Book value per share | $4.55 | $5.44 | $6.55 | $5.57 | $17.79 | — | — | — | — | — | — |
| Shares outstanding | 5.4M | 5.4M | 4.5M | 2.2M | 1.6M | — | — | — | — | — | — |
| Current ratio | 27.85 | 14.31 | 9.04 | 2.72 | 3.56 | 11.01 | 2.06 | 3.30 | 3.45 | 3.81 | 3.30 |
| Quick ratio | 27.33 | 13.91 | 9.00 | 2.66 | 5.23 | 11.00 | 2.05 | 3.21 | 3.33 | 2.39 | 3.21 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 |
| Equity / assets | 85.7% | 84.5% | 81.2% | 45.8% | 66.5% | 84.6% | 75.7% | 74.5% | 63.3% | 74.7% | 74.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed September 18, 2026); data from EODHD.
NEUP financial position
At the end of fiscal 2026 (June 30, 2026), Neuphoria Therapeutics had total assets of $28.7 billion (up 65,990.3% from a year earlier), total liabilities of $4.1 billion and shareholders' equity of $24.6 billion. It held $19.9 billion in cash and short-term investments against $0.0 million of debt, a net cash position of $19.9 billion. Its current ratio was 27.85.
Related: NEUP income statement, NEUP cash flow statement, NEUP key metrics. See the NEUP stock overview for the latest quote and news.
NEUP balance sheet FAQ
What are Neuphoria Therapeutics's total assets?
Neuphoria Therapeutics reported total assets of $28.7 billion at the end of fiscal 2026 (June 30, 2026), compared with $43.4 million a year earlier.
How much debt does Neuphoria Therapeutics have?
Neuphoria Therapeutics had $0.0 million of total debt at the end of fiscal 2026, including short-term borrowings. Its debt-to-equity ratio was 0.00.
How much cash does Neuphoria Therapeutics have?
Neuphoria Therapeutics held $19.9 billion in cash and short-term investments at the end of fiscal 2026; with $0.0 million of debt that is net cash of $19.9 billion.
What is Neuphoria Therapeutics's book value?
Neuphoria Therapeutics's shareholders' equity (book value) was $24.6 billion at the end of fiscal 2026, or $5,596.00 per share.
What is Neuphoria Therapeutics's current ratio?
Neuphoria Therapeutics had current assets of $21.1 billion and current liabilities of $756.6 million, a current ratio of 27.85 (it can cover its short-term obligations).
How much goodwill does Neuphoria Therapeutics have?
Neuphoria Therapeutics carried $7.6 billion of goodwill and intangible assets, 26.6% of total assets, at the end of fiscal 2026.